Lista de obras -

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region

artículo científico publicado en 2006

All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes

artículo científico publicado en 2018

Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes

artículo científico publicado en 2004

Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes

artículo científico publicado en 2004

Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes

artículo científico publicado en 2005

Association analysis of the lymphocyte-specific protein tyrosine kinase (LCK) gene in type 1 diabetes

artículo científico publicado en 2004

Association of intercellular adhesion molecule-1 gene with type 1 diabetes

artículo científico publicado en 2003

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

artículo científico publicado en 2003

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

scientific article published on 11 November 2018

Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene

artículo científico publicado en 2004

Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes

artículo científico publicado en 2005

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.

artículo científico publicado en 2018

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.

artículo científico publicado en 2018

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin added to metformin monotherapy on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study

artículo científico publicado en 2018

Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial

scientific article published on 18 August 2020

Evolution of Inflammatory and Oxidative Stress Markers in Romanian Obese Male Patients with Type 2 Diabetes Mellitus after Laparoscopic Sleeve Gastrectomy: One Year Follow-Up

artículo científico publicado en 2020

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

artículo científico publicado en 2019

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: pooled analysis of randomized active controlled clinical trials

scientific article published on 23 April 2020

Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes

artículo científico

No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes

artículo científico publicado en 2005

Parameters for reliable results in genetic association studies in common disease

article

Rates and Causes of Death among Adult Diabetes Patients in Romania

scientific article published on 13 November 2018

Remapping the insulin gene/IDDM2 locus in type 1 diabetes

artículo científico publicado en 2004

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus

artículo científico publicado en 2004

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

artículo científico publicado en 2007

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Cont

artículo científico publicado en 2018

Sera of Obese Type 2 Diabetic Patients Undergoing Metabolic Surgery Instead of Conventional Treatment Exert Beneficial Effects on Beta Cell Survival and Function: Results of a Randomized Clinical Study

artículo científico publicado en 2019

The role of paraoxonase 2 (PON2) in modulating the oxidant-antioxidant balance of the peripheral blood mononuclear cells in newly diagnosed type 2 diabetic patients

Lista de obras de

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region

All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes

Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes

Analysis of the vitamin D receptor gene sequence variants in type 1 diabetes

Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes

Association analysis of the lymphocyte-specific protein tyrosine kinase (LCK) gene in type 1 diabetes

Association of intercellular adhesion molecule-1 gene with type 1 diabetes

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene

Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin added to metformin monotherapy on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study

Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial

Evolution of Inflammatory and Oxidative Stress Markers in Romanian Obese Male Patients with Type 2 Diabetes Mellitus after Laparoscopic Sleeve Gastrectomy: One Year Follow-Up

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: pooled analysis of randomized active controlled clinical trials

Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes

No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes

Parameters for reliable results in genetic association studies in common disease

Rates and Causes of Death among Adult Diabetes Patients in Romania

Remapping the insulin gene/IDDM2 locus in type 1 diabetes

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Cont

Sera of Obese Type 2 Diabetic Patients Undergoing Metabolic Surgery Instead of Conventional Treatment Exert Beneficial Effects on Beta Cell Survival and Function: Results of a Randomized Clinical Study

The role of paraoxonase 2 (PON2) in modulating the oxidant-antioxidant balance of the peripheral blood mononuclear cells in newly diagnosed type 2 diabetic patients